Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Israeli pharmaceutics company Teva, the owner of Croatian Pliva, has decided to sell its company TAPI. Because of this, TAPI has announced plans to shut down the company on 01 May 2024 and make 130 employees redundant.
Some of the experts will be employed in the new Pliva Centre of Excellence for Research and Development of Small Molecules, while others will obtain relatively high severance payments. The new Centre of Excellence will support Teva's business in the area of research into innovative molecules and the development of new forms of existing molecules. The intention is to strengthen Teva's future portfolio of innovative drugs and maintain Teva's position as a powerful company.
TAPI research and development, which deals with active pharmaceutical ingredients globally is located in Zagreb.
Eurofound (2024), Pliva - TAPI , Closure in Croatia, factsheet number 201146, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/201146.